Exelixis
EXEL
#1622
Rank
C$18.47 B
Marketcap
C$73.52
Share price
0.76%
Change (1 day)
27.42%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company